Skip to content
MedsAcross

Molecule

Oxiconazole

Also known as oxiconazole nitrate
Available on requestDermatology
Presentations
2
Brands
1
Manufacturers
1
Available from stock
0

Oxiconazole is an azole antifungal indicated for the topical treatment of dermal infections. It is available as cream and lotion for topical use. MedsAcross supplies Oxiconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Azole Antifungal
ATC classification
D01AC11 Oxiconazole · Antifungals for the skin, subgroup D01A, subgroup D01ACG01AF17 Oxiconazole · Gynaecological anti-infectives, subgroup G01A, subgroup G01AF
US FDA first approval
30 December 1988
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Topical
Dosage forms
Cream, Lotion
Identifiers
UNII C668Q9I33JRxCUI 32638CAS 64211-45-6DrugBank DB00239Q3359058

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Oxiconazole nitrate cream is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, or Epidermophyton floccosum. Oxiconazole nitrate cream is indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur. Oxiconazole nitrate cream may be used in pediatric patients for tinea corporis, tinea cruris, tinea pedis, and tinea (pityriasis) versicolor, however, these indications for which oxiconazole nitrate cream has been shown to be effective rarely occur in children below the age of 12.

Source: US FDA prescribing information

Dosing overview

Oxiconazole nitrate cream should be applied to affected and immediately surrounding areas once to twice daily in patients with tinea pedis, tinea corporis, or tinea cruris. Oxiconazole nitrate cream should be applied once daily in the treatment of tinea (pityriasis) versicolor. Tinea corporis, tinea cruris, and tinea (pityriasis) versicolor should be treated for 2 weeks and tinea pedis for 1 month to reduce the possibility of recurrence. If a patient shows no clinical improvement after the treatment period, the diagnosis should be reviewed. Note: Tinea (pityriasis) versicolor may give rise to hyperpigmented or hypopigmented patches on the trunk that may extend to the neck, arms, and upper thighs. Treatment of the infection may not immediately result in restoration of pigment to the affected sites.

Source: US FDA prescribing information

Contraindications

Oxiconazole nitrate cream is contraindicated in individuals who have shown hypersensitivity to any of their components.

Source: US FDA prescribing information

Side effects

During clinical trials, of 955 patients treated with oxiconazole nitrate cream, 1%, 41 (4.3%) reported adverse reactions thought to be related to drug therapy. These reactions included pruritus (1.6%), burning (1.4%), irritation and allergic contact dermatitis (0.4% each), folliculitis (0.3%), erythema (0.2%), and papules, fissure, maceration, rash, stinging, and nodules (0.1% each).

Source: US FDA prescribing information

Interactions

Potential drug interactions between oxiconazole nitrate and other drugs have not been systematically evaluated. Drug Interactions: Potential drug interactions between oxiconazole nitrate and other drugs have not been systematically evaluated.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

2 presentations of Oxiconazole, sorted by availability.

MedicineManufacturerRegisterAvailability
Oxiconazole 1% creamTopicalGeneric name—US FDAAvailable on request
Oxistat 10 mg/mL lotionTopicalANI PharmaceuticalsUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Oxistat

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 30 December 1988Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Oxiconazole in public data. This is not a list of approved uses, see the clinical information.

Cutaneous candidiasis Pityriasis versicolor Tinea Tinea corporis Tinea cruris Tinea pedis

Questions and answers

Is Oxiconazole available for export from India?

Yes, on request. MedsAcross lists 2 presentations of Oxiconazole and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Oxiconazole have?

The catalogue lists 1 brand names for Oxiconazole, including Oxistat.

Is Oxiconazole approved by the US FDA?

Yes. The US FDA first approved Oxiconazole on 30 December 1988, according to Drugs@FDA.

Does Oxiconazole need cold chain shipping?

No listed presentation of Oxiconazole is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Oxiconazole in?

Oxiconazole is classified under ATC code D01AC11 (Oxiconazole).

References

  1. Oxiconazole Nitrate prescribing information (E. Fougera). U.S. National Library of Medicine, DailyMed. Retrieved 28 January 2026

Request Oxiconazole for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.

Request a quoteRead the import guides